Announcement on Voluntary Disclosure of Inclusion of Recombinant Human Thrombin into the Catalogue Of Drugs For Basic National Medical Insurance in 2024

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Inclusion of Recombinant Human Thrombin into the Catalogue Of Drugs For Basic National Medical Insurance in 2024The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A